GlucoModicum publishes first-in-human data assessing the safety and effectiveness of its MHD technology for accurate needle-free glucose monitoring lnkd.in/gb5R5aQt
GlucoModicum has closed +1,2M EUR Seed Round | University of Helsinki helsinki.fi/en/news/life-sci…
GlucoModicum: Needle-free and painless health monitoring | University of Helsinki helsinki.fi/en/news/health-n…
GlucoModicum retweeted
.@GlucoModicum, presented by the CEO Jokke Maki has created a solution for needle-free monitoring which enables non-invasively sample analysis. #teamfinlandfi #finembsin #finlandhealth
News: Health Design 2017 brought together healthcare, design, and technology professionals aalto.fi/en/current/news/201…
GlucoModicum retweeted
Neulatonta verensokerin mittausmenetelmää @helsinkiuni kehittävä @GlucoModicum esillä #slush17 Ratkaisu liitettävissä osaksi älykelloa tai aktiivisuusranneketta tai uudenlaiseen taskukokoiseen glukoosimittariin. helsinki.fi/fi/uutiset/terve… #diabetesfi – at Helsinki, Finland



